Grant A. Krafft
Acumen Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Organoselenium and organotellurium chemistry, Cholinesterase and Neurodegenerative Diseases, Sulfur-Based Synthesis Techniques
Most-Cited Works
- → Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins(1998)3,485 cited
- → Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability(2002)1,435 cited
- → Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss(2003)1,048 cited
- → In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis(2003)1,008 cited
- → Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers(2004)951 cited
- → Novel Fluorogenic Substrates for Assaying Retroviral Proteases by Resonance Energy Transfer(1990)593 cited